To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy.

NCT07081256 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

665

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-Induced Nausea and Vomiting

Interventions

DRUG: QLM2010 for injection；dexamethasone
DRUG: fosaprepitant dimeglumine for injection；palonosetron hydrochloride injection；dexamethasone

Sponsor

Qilu Pharmaceutical Co., Ltd.